With the environment now focused on high drug pric

With the environment now focused on high drug prices, it is understandable NP did say publicly last time he was asked. Some will just bypass the 15 years, 250M dollars it took leronlimab to get to this point and focus on the cost to produce versus price.

But he did answer in 2017, my previous post linked, this is 350mg two injections of 175mg or 1ml, I believe. So 104 1ml shots cost $4k or around $40 each. I assume 2ml would be double, so around $80.

I assume 525mg will be a 1ml and 2 ml shot (175mg + 350mg), so $120 per week or ~$6,000 cost per year and and 700mg will be two 2ml shots or $160 per week or ~$8000 cost per year. Assuming a 50-50 spilt on 525 vs 700mg that would be or average cost of $7000 per patient per year. With that being ~6% or around $6M... just a guess

Also, 75% of the manufacturing needing with 2ml shots and 25% needing 1ml shots. Unless they go to say a 3ml shot for 525mg (or 2 1.5mg shots)

Quote:

---

Here is a question from the Jan 2017 CC.
https://seekingalpha.com/article/4034678-cyto...art=single

Quote:
Well, can you give us some idea what the relative to us, you said your cost of manufacture is going to be substantially less? Could you give us some relative idea…

Dr. Nader Pourhassan

Yes. It could be as low as $3000 to $4000 per year treatment and that’s giving a patient two injections a week,


Read More: https://investorshangout.com/post/view?id=533...z61gxcOjDG

---